Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors

• Status: Completed
• Trial end date: 2007-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a sixteen-week follow-on and 28 week single-blind extension study for patients who participated in study NK-104-304.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kowa Research Europe
• Treatments: Pitavastatin; Simvastatin

Criteria

Inclusion Criteria:

• Completed NK-104-304 (NCT 00309738)

• Hypercholesterolemia or combined dyslipidemia

• 2 or more risk factors for coronary heart disease (CHD)

Exclusion Criteria:

• Withdrawn or terminated from NK-104-304 (00309738)